Cary Street Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
Cary Street Partners's MRK Position: Q2 2026 in Review
Cary Street Partners reduced its Merck (MRK) stake by 0.05% in Q2 2026, selling an estimated $11.7K and leaving 201,087 shares worth $25.8M. The position accounts for 0.56% of the portfolio, ranked #37.
Cary Street Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cary Street Partners held 201,087 shares of Merck worth $25.8M as of Q2 2026.
- Cary Street Partners sold 100 Merck shares in Q2 2026, an estimated $11.7K.
- Merck made up 0.56% of Cary Street Partners's portfolio in Q2 2026, its #37 holding.
- Cary Street Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.